Remed Statistics

Total Valuation

Remed has a market cap or net worth of KRW 98.04 billion. The enterprise value is 97.42 billion.

Market Cap	98.04B
Enterprise Value	97.42B

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Remed has 30.64 million shares outstanding. The number of shares has increased by 4.90% in one year.

Current Share Class	n/a
Shares Outstanding	30.64M
Shares Change (YoY)	+4.90%
Shares Change (QoQ)	+9.66%
Owned by Insiders (%)	36.18%
Owned by Institutions (%)	2.77%
Float	19.55M

Valuation Ratios

The trailing PE ratio is 14.35.

PE Ratio	14.35
Forward PE	n/a
PS Ratio	3.84
PB Ratio	2.44
P/TBV Ratio	2.54
P/FCF Ratio	148.87
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 42.48, with an EV/FCF ratio of 147.92.

EV / Earnings	13.58
EV / Sales	3.81
EV / EBITDA	42.48
EV / EBIT	95.93
EV / FCF	147.92

Financial Position

The company has a current ratio of 4.23, with a Debt / Equity ratio of 0.18.

Current Ratio	4.23
Quick Ratio	2.80
Debt / Equity	0.18
Debt / EBITDA	3.24
Debt / FCF	11.80
Interest Coverage	0.96

Financial Efficiency

Return on equity (ROE) is 20.13% and return on invested capital (ROIC) is 1.41%.

Return on Equity (ROE)	20.13%
Return on Assets (ROA)	1.23%
Return on Invested Capital (ROIC)	1.41%
Return on Capital Employed (ROCE)	2.14%
Revenue Per Employee	280.81M
Profits Per Employee	78.81M
Employee Count	91
Asset Turnover	0.45
Inventory Turnover	1.87

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.61% in the last 52 weeks. The beta is 0.82, so Remed's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	+13.61%
50-Day Moving Average	3,311.40
200-Day Moving Average	3,346.43
Relative Strength Index (RSI)	44.21
Average Volume (20 Days)	187,439

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Remed had revenue of KRW 25.55 billion and earned 7.17 billion in profits. Earnings per share was 223.00.

Revenue	25.55B
Gross Profit	14.05B
Operating Income	1.12B
Pretax Income	8.05B
Net Income	7.17B
EBITDA	2.40B
EBIT	1.12B
Earnings Per Share (EPS)	223.00

Full Income Statement

Balance Sheet

The company has 10.68 billion in cash and 7.77 billion in debt, giving a net cash position of 2.91 billion or 94.82 per share.

Cash & Cash Equivalents	10.68B
Total Debt	7.77B
Net Cash	2.91B
Net Cash Per Share	94.82
Equity (Book Value)	42.53B
Book Value Per Share	1,313.68
Working Capital	21.87B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.24 billion and capital expenditures -585.95 million, giving a free cash flow of 658.57 million.

Operating Cash Flow	1.24B
Capital Expenditures	-585.95M
Free Cash Flow	658.57M
FCF Per Share	21.50

Full Cash Flow Statement

Margins

Gross margin is 54.97%, with operating and profit margins of 4.39% and 28.07%.

Gross Margin	54.97%
Operating Margin	4.39%
Pretax Margin	31.48%
Profit Margin	28.07%
EBITDA Margin	9.39%
EBIT Margin	4.39%
FCF Margin	2.58%

Dividends & Yields

Remed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.90%
Shareholder Yield	-4.90%
Earnings Yield	7.32%
FCF Yield	0.67%

Stock Splits

The last stock split was on December 8, 2023. It was a forward split with a ratio of 5.

Last Split Date	Dec 8, 2023
Split Type	Forward
Split Ratio	5

Scores

Remed has an Altman Z-Score of 4.72.

Altman Z-Score	4.72
Piotroski F-Score	n/a